Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection —  announced the introduction of its Easydrip™ Plus pen needles into the Turkish market through a leading regional diabetes distributor with a nationwide pharmacy network. The launch is already unlocking interest from neighbouring Middle‑East markets.

Key advantages

• Hextra Tech hexagonal hub — a broad, six‑facet platform that helps patients keep the pen steady during insertion, reducing wobble, bruising and needle bending versus conventional narrow‑hub pen needles.
• Greater dosing confidence — the enlarged contact surface promotes a consistent injection angle, supporting accurate sub‑cutaneous delivery.
• Thin‑wall cannula with silicone lubrication — minimises penetration force and shortens injection time for a gentler daily routine.

Market relevance

As the first pen needle with a patent‑protected hexagonal hub available in Turkey, Easydrip™ Plus is already attracting interest from neighbouring countries and sets a practical alternative between premium global brands and low‑end generics.

Availability & next steps

• Current channel: nationwide community pharmacies, often bundled with blood‑glucose meters.
• Planned expansion: influencer‑driven digital campaigns and e‑commerce to reach online‑first consumers across Turkey and neighbouring states.

Certifications

Easydrip™ Plus is manufactured under a strict ISO 13485 quality system and holds CE Declaration of Conformity, meeting international safety and performance standards.

Brand Relationship

Sandstone Medical is SteriLance Medical's diabetes‑care brand focused on self‑injection. Easydrip™ products are developed and marketed by Sandstone, with SteriLance providing manufacturing and quality systems under ISO 13485.